title: [Anti-tumor necrosis factor drug therapy: The usefulness of monitoring drug levels and anti-drug antibodies in clinical practice].
authors.affiliation: Unidad de Inmunología, Complejo Asistencial Universitario e Instituto de Biomedicina Universidad de León (IBIOMED), León, España. Electronic address: jmgarciar@saludcastillayleon.es.
authors.forename: Jose M
authors.initials: JM
authors.lastname: García Ruiz de Morales
authors.affiliation: Unidad de Inmunología e Instituto de Investigación Sanitaria, Hospital Universitario La Paz (IdiPAZ), Madrid, España. Electronic address: dora.pascualsalcedo@salud.madrid.org.
authors.forename: Dora
authors.initials: D
authors.lastname: Pascual-Salcedo
authors.affiliation: Servicio de Análisis Clínicos, Hospital Marina Baixa, Villajoyosa, Alicante, España.
authors.forename: Francisca
authors.initials: F
authors.lastname: Llinares Tello
authors.affiliation: Servicio de Reumatología e Instituto de Investigación Biomédica, Hospital General Universitario Gregorio Marañón, Madrid, España.
authors.forename: Larissa
authors.initials: L
authors.lastname: Valor Méndez
mesh_terms: D000893:Anti-Inflammatory Agents / Q000097:blood / Q000276:immunology / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized / Q000097:blood / Q000276:immunology / Q000493:pharmacokinetics*; D001682:Biological Availability; D015415:Biomarkers / Q000097:blood; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000276:immunology / Q000493:pharmacokinetics*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha